A recent study has calculated the average cost for drug development (including marketing approval) at $2.558 billion. According to Tufts Center for the Study of Drug Development, this figure was reached through estimating average out-of-pocket costs to be $1.395 billion and time costs to be $1.163 billion. Once the drug is approved, R&D costs for […]

There is likely to be an increase in spending by the pharmaceutical industry for 2016 due to an upsurge in demand. The long-term outlook for pharma is mostly positive, with projected average growth of 4.3% between 2015 and 2019, totaling $1.4 trillion in global pharma sales by 2019. The US, Brazil, Russia and China collectively […]

A survey of 52 pharmaceutical industry and academic personnel involved in natural products (NP) drug discovery found a gap between NP drug discovery strategies and NP drug potential. Thirty-five respondents chose high-throughput screening (HTS) as the “top preferred current strategy.” However, it is not best suited for NP drug discovery, according to many respondents. For […]

According to a new report by Deloitte, R&D return on investments generated from the pharmaceutical industry’s annual investment in new product innovation have continued to decline. The annual projected R&D returns were 10.1% in 2010; in 2015, the returns were down to 4.2%. Since 2010, Deloitte’s original cohort of 12 companies has launched 186 products […]

By 2020, spending on medicines will total $1.4 trillion, a 29%–32% increase in constant dollars from 2015, but down from 35% growth over the previous five-year period. The volume of medicines used from 2015 to 2020 will increase 24%. Original brands, nonoriginal brands, unbranded and OTC medicines will account for 52%, 21%, 14% and 13% […]